Welcome to our dedicated page for Darling Ingred SEC filings (Ticker: DAR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Darling Ingredients Inc. (NYSE: DAR) provides access to the company’s regulatory disclosures as an issuer listed on the New York Stock Exchange. Through forms such as 10-K, 10-Q, and 8-K, Darling Ingredients reports information about its operations in rendering and meat byproduct processing, its sustainable ingredients business, and its financial condition.
Current reports on Form 8-K offer detailed insight into specific events. For example, the company has filed 8-Ks describing quarterly financial results, including segment data for feed ingredients, food ingredients, and fuel ingredients, as well as non-GAAP measures like Segment Adjusted EBITDA and Combined Adjusted EBITDA. These filings also discuss the performance of the Diamond Green Diesel joint venture and its impact on Darling Ingredients’ earnings.
Other 8-K filings address capital structure and financing, such as the redemption of senior notes, satisfaction and discharge of related indentures, and the pricing of new senior notes issued by an indirect wholly owned subsidiary. Governance-related filings include amendments and restatements of the company’s bylaws and executive leadership changes, including departures, retirement plans, and advisory arrangements for certain officers.
Filings also document strategic transactions. A Form 8-K describes the Master Contribution Agreement under which Darling Ingredients and Tessenderlo Group will contribute their collagen and gelatin business assets and liabilities into NewCo Collagen LLC, with Darling Ingredients expected to hold an 85% equity interest and Tessenderlo a 15% interest at closing, subject to regulatory approvals and other conditions.
On this page, users can review these SEC documents and use AI-powered summaries to interpret complex sections, such as segment reconciliations, non-GAAP measures, and transaction terms. Real-time updates from EDGAR, combined with AI explanations of 10-K annual reports, 10-Q quarterly reports, and 8-K current reports, help readers understand how specific filings relate to Darling Ingredients’ core ingredients business, its Diamond Green Diesel joint venture, and its collagen and gelatin initiatives.
Darling Ingredients Chairman and CEO Randall C. Stuewe exercised stock options and had shares withheld for taxes. He exercised options covering 353,152 shares on
Darling Ingredients Inc. director Robert Patrick Aspell reported an equity grant of company stock. On this Form 4, he acquired 549 shares of common stock as a grant or award at a stated price of $0.00 per share. Following this transaction, his directly owned stake stands at 549 common shares.
DARLING INGREDIENTS INC. director Robert Patrick Aspell filed an initial insider ownership report showing that he currently has no securities beneficially owned in the company. The Form 3 indicates zero shares held directly after the reported position, meaning he reports no equity stake at this time.
Darling Ingredients Inc. reported upcoming board changes and a new director appointment. Long‑time director Gary W. Mize, a board member since 2016 and Lead Director since 2021, plans to retire effective at the company’s 2026 Annual Meeting of Stockholders, remaining in his roles until then.
The board elected Robert Aspell as an independent director effective immediately and expanded the board size to eleven members. Aspell was also appointed to the Audit Committee. He will receive the standard non‑employee director package, including a $100,000 annual cash retainer and an annual grant of $150,000 in restricted stock units, prorated for his first year.
Darling Ingredients Inc. executive vice president Jan van der Velden reported selling a total of 23,000 shares of common stock in two open-market transactions. On February 18, he sold 3,000 shares at a price of
Darling Ingredients EVP Chief Strategy Officer Sandra Dudley reported several stock transactions on February 13, 2026. She exercised options to acquire 8,431 shares of common stock at $12.29 per share under the company’s 2017 Omnibus Incentive Plan.
To cover the exercise price or taxes, 3,575 shares were disposed of at $51.86 through a tax-withholding transaction. She also sold 4,856 shares at $51.86, 1,464 shares at $51.57, and 2,331 shares at $51.76 in open-market sales. After these transactions, she directly owned 71,100 shares of Darling Ingredients common stock.
Darling Ingredients EVP, General Counsel & Secretary Nicholas James Kemphaus reported multiple equity transactions in the company’s stock. On February 13, 2026, he exercised 5,760 stock options at an exercise price of
On the same date, he used 3,099 shares of common stock at
Darling Ingredients director Celeste Clark reported an amended equity award, acquiring 1,594 deferred stock units (DSUs) of common stock on January 2, 2026 at $37.64 per share under the 2017 Omnibus Incentive Plan. The filing corrects a previously underreported DSU amount caused by an administrative error.
After this grant, Clark beneficially owned 17,787 shares of common stock directly. The DSUs vest in full on December 31, 2026, but will vest on a prorated basis if she leaves the board earlier, with any remaining unvested DSUs forfeited.
Darling Ingredients Inc. received a Rule 144 notice covering a planned sale of 25,000 shares of its common stock through broker Virtu Financial on the NYSE. Based on recent prices used in the notice, the aggregate market value of the shares is stated as $1,274,000.
The filing notes that these shares were acquired through performance stock unit (PSU) and restricted stock unit (RSU) vesting from January 1, 2014 through January 6, 2026. The notice also reports that 158,367,070 shares of Darling Ingredients common stock were outstanding, providing context for the size of the planned sale.
Darling Ingredients Inc. is the issuer for a planned stock sale under Rule 144. A holder intends to sell 100,000 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of
The securities were originally acquired from the issuer on